2025-07994Notice

US Blocks Copycat Heart Drugs: Patent Wars Heat Up

Published Date: 5/8/2025

Notice

Summary

BioMarin Pharmaceutical is asking the U.S. International Trade Commission to investigate some imported drug products that might be breaking their patent rules. This could lead to stopping those products from being sold in the U.S., affecting companies involved in making or selling these drugs. The investigation started in April 2025 and could change who gets to sell these medicines and when.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
4/2/2025
5/8/2025

Department and Agencies

Department
Independent Agency
Agency
International Trade Commission
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register